CNBC: Black health leaders try to build trust in the COVID-19 vaccine among African Americans
Louito Edje, MD, wants to inspire confidence in COVID-19 vaccine
African-American health professionals and community health groups across the country have already begun to do outreach in Black communities hit hard by the coronavirus.
Seven out of 10 African Americans know someone who’s been hospitalized or died from COVID-19, according to a Pew Research poll conducted last month. Yet vaccine skepticism runs high. Only 42% of Blacks surveyed say they plan to be vaccinated, compared with more than 60% for Americans overall.
The vaccine is almost here, but we can't get to a new normal if people don't take the shot. According to a Pew survey, only about 60% of Americans say they'll get the vaccine. However, only 42% of black adults say they'll get it.
— The News with Shepard Smith (@thenewsoncnbc) December 11, 2020
CNBC's @berthacoombs has the story. pic.twitter.com/WvdTOyUPIg
Louito Edje, MD, associate dean of graduate medical education at the UC College of Medicine and UC Medical Center, enrolled in the Phase 3 clinical trial for SARS-CoV-2 vaccine after three of her relatives died from the coronavirus. UC is one of approximately 90 sites in the country to host a trial for the mRNA-1273 vaccine developed by the National Institute of Allergy and Infectious Diseases scientists and collaborators at biotechnology company Moderna.
Edje holds a master's of health professions education and is a fellow of the American Academy of Family Physicians. She wanted to set an example and inspire confidence in her patients to get vaccinated. Edje shared her story with CNBC as part of a segment including interviews from health professionals across the country and community groups promoting vaccination against COVID-19. “I felt that I might be able to have an impact that has some credibility, for the patients that I take care of every day who look just like me,” Edje told CNBC.
Learn more about Dr. Edje online.
Featured image with Louito Edje, MD, in front of the UC College of Medicine by Colleen Kelley/University of Cincinnati.
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.